Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CHRM2 | P08172 | 1/20 | 0.60 |
| ▸ | KDM4E | B2RXH2 | 4/20 | 0.55 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.55 |
| ▸ | ACHE | P22303 | 2/20 | 0.50 |
| ▸ | HRH3 | Q9Y5N1 | 2/20 | 0.47 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.46 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.43 |
| ▸ | RAB9A | P51151 | 1/20 | 0.43 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28577080 | 0.85 | KDM4E (0.60) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| SCHEMBL28572335 | 0.85 | KDM4E (0.60) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| SCHEMBL25634668 | 0.85 | CHRM2 (0.62) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| SCHEMBL28914380 | 0.84 | KDM4E (0.59) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| SCHEMBL28524774 | 0.84 | CHRM2 (0.68) | CHRM2KDM4EALDH1A1ACHE | |
| SCHEMBL27997282 | 0.82 | KDM4E (0.61) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| SCHEMBL15800205 | 0.81 | KDM4E (0.67) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| SCHEMBL31420448 | 0.81 | ACHE (0.55) | CHRM2KDM4EALDH1A1ACHEHRH3 | |
| Carbamic Acid SCHEMBL29018025 | 0.80 | CHRM2 (0.69) | CHRM2KDM4EALDH1A1ACHEMCHR1 | |
| SCHEMBL28204841 | 0.78 | CHRM2 (0.61) | CHRM2KDM4EALDH1A1ACHEMCHR1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115403509-A | Preparation method of lefenacin intermediate | 山东新时代药业有限公司 | 2022-11-29 | — | — | CN | disclosed |